deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT00734201

Safety and Efficacy of Low Doses of V24343 in Obese Subjects

A Double-blind, Placebo-controlled, Parallel Group Study of the Effect of V24343 on Blood Pressure and Weight in Obese Subjects

Sponsor: Vernalis (R&D) Ltd

Conditions Obesity
Interventions V24343
Updated 5 times since 2017 Last updated: Jul 21, 2011 Started: Oct 31, 2008 Primary completion: Mar 31, 2009 Completion: Mar 31, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00734201, this PHASE1 trial focuses on Obesity and remains completed. Sponsored by Vernalis (R&D) Ltd, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Vernalis (R&D) Ltd
Data source: Vernalis (R&D) Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations